Apoptosis-Inducing Fe²⁺/β-Cyclodextrin Supramolecular Nano-Particulate Complex as an Anticancer Drug Platform and...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Materials Science

Background:

• Beta-cyclodextrin (β-CD) metal complexes are a growing area in medicine.
• Developing novel drug delivery systems is crucial for effective cancer treatment.

Purpose of the Study:

• To synthesize and characterize an iron/β-cyclodextrin (Fe(II)-β-CD) nanocomplex.
• To evaluate the in vitro biocompatibility and anticancer potential of the Fe(II)-β-CD nanocomplex.
• To investigate the molecular interactions of the nanocomplex with cancer biomarkers.

Main Methods:

• Synthesis of Fe(II)-β-CD nanocomplex at room temperature.
• Characterization using various analytical techniques.
• In vitro cytotoxicity assays on liver, breast, lung, and prostate cancer cell lines.
• Molecular docking studies against CD44 glycoprotein.

Main Results:

• The Fe(II)-β-CD nanocomplex has a porous structure (4-10 nm) and is stable and biocompatible under physiological conditions.
• The nanocomplex demonstrated no cytotoxic effect on tested cancer cell lines.
• Apoptotic cell death was observed as the primary mode of cell death.
• Molecular docking indicated potential as an anticancer agent targeting CD44.

Conclusions:

• Fe(II)-β-CD nanocomplexes are promising biocompatible drug delivery platforms.
• The nanocomplex exhibits anticancer potential through apoptosis induction.
• This research paves the way for using similar complexes in cancer therapy targeting specific biomarkers.